Yifei Sanjie pill combined with gefitinib reduces the progression of EGFR-TKIs-resistant non-small cell lung cancer via YAP/ANKRD1 axis

Phytomedicine 2026

View at publisher
Authors: Yi Yuan, Ruisheng Zhou, Zengjie Ye, Lunwei Yang, Tianqi Gao, Huilin Xu, Xi Can Tang, Xi Tang, Dailin Wu, Zilong Lin, Zilong Lin, Zilong Lin
+7 more Yuehua Luo, Binbin Qin, Le Li, Chuangjie Zheng, Jinfang Zhang, Ying Tang, Lizhu Lin
DOI: 10.1016/j.phymed.2026.158003
Cited by: 1
References: 51

Fields of Study & Subjects

Hippo pathway signaling and YAP/TAZ Lung Cancer Treatments and Mutations Protein Degradation and Inhibitors

Publication details

Journal / source
Phytomedicine
Publisher
Elsevier BV
Volume
155
Pages
158003–158003
Publication date
23 February 2026
Language
EN